Rana Hashemi

Dr. Rana Hashemi

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 November 2024 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
BHBardia Hajikarimloo
Bardia Hajikarimloo
MHMohammad Amin Habibi
Mohammad Amin Habibi
MAMohammad-Amin Abdolahifar
Mohammad-Amin Abdolahifar
SMSima Osouli Meinagh
Sima Osouli Meinagh
AKAlireza Kooshki
Alireza Kooshki
AHArman Hasanzade
Arman Hasanzade

24 January 2025 in Neurosurgical Review
Verified
Journal Article
Closed access
PDF file
BHBardia Hajikarimloo
Bardia Hajikarimloo
Ibrahim MohammadzadehIbrahim Mohammadzadeh
Ibrahim Mohammadzadeh
MNMohammad Ali Nazari
Mohammad Ali Nazari
MHMohammad Amin Habibi
Mohammad Amin Habibi
Pourya TaghipourPourya Taghipour
Pourya Taghipour
STSalem M. Tos
Salem M. Tos

19 May 2022 in European Journal of Translational Myology
Verified
Journal Article
Open access
PDF file
MHMohammad Hassani
Mohammad Hassani
MMMahdi Mohebbi
Mahdi Mohebbi
MTMehdi Tavallaei
Mehdi Tavallaei
SNSeyed Mohammad Reza Hosseini Nodoushan
Seyed Mohammad Reza Hosseini Nodoushan
MMMoein Mirzadeh
Moein Mirzadeh
RHRana Hashemi
Rana Hashemi
Renal transplant therapy is essential in patients with End-Stage Renal Disease (ESRD). It is used in patients awaiting a kidney transplant or those who cannot be a transplant candidate. Central venous catheter is one of the most used access routes worldwide but has been recorded as the one with highest mortality and morbidity rate. Thromboembolic events have played a major part for that. This is a descriptive-analytical study, which conducted in a university treatment center in Tehran, Iran. A total of 225 patients were selected for this study that 108 were excluded because of our criteria. Statistical analysis was performed by SPSS v19 and a total of 117 patients were included in this study. The average age of the patients was 51.62±11.26. 79 (67.5%) and 38 (32.5%) patients had medial and lateral tip direction, respectively. The catheter of 85(72.6%) and 32(27.4%) patients was patent and occluded, respectively. The average catheter tip occlusion time in both groups was 22.5 and 7.5 months. Three-month, six-month, twelve-month, and twenty-four-month patency rate were 99%, 94%, 88%, and 30%, respectively. our findings suggest that medial direction of the tip of the catheter reduces complications caused in CVS. Because our study has been conducted in a small scale and there is lack of similar studies, our team suggests extension to a larger scale to confirm or not our results.

31 March 2025 in Neuroradiology
Verified
Journal Article
Closed access
PDF file
BHBardia Hajikarimloo
Bardia Hajikarimloo
STSalem M. Tos
Salem M. Tos
AKAlireza Kooshki
Alireza Kooshki
MAMohammad-Amin Abdolahifar
Mohammad-Amin Abdolahifar
MEMohammad Shahir Eftekhar
Mohammad Shahir Eftekhar
MHMohammad Amin Habibi
Mohammad Amin Habibi

14 June 2025 in European Spine Journal
Verified
Journal Article
Closed access
PDF file
BHBardia Hajikarimloo
Bardia Hajikarimloo
Ibrahim MohammadzadehIbrahim Mohammadzadeh
Ibrahim Mohammadzadeh
AEAzin Ebrahimi
Azin Ebrahimi
STSalem M. Tos
Salem M. Tos
RHRana Hashemi
Rana Hashemi
MHMohammad Amin Habibi
Mohammad Amin Habibi

25 August 2025 in Neuroradiology
Verified
Journal Article
Closed access
PDF file
BHBardia Hajikarimloo
Bardia Hajikarimloo
STSalem M. Tos
Salem M. Tos
ASAbhishek Saha
Abhishek Saha
Ibrahim MohammadzadehIbrahim Mohammadzadeh
Ibrahim Mohammadzadeh
AMAli Mortezaei
Ali Mortezaei
MHMohammad Amin Habibi
Mohammad Amin Habibi